Women’s Health: Enrollment Opening Soon

Perimenopause, menopause, and post-menopause are medical events with measurable consequences, and evidence-based treatment options that most women are never offered.
Member-only pricing on all treatments
Crimson protocols are designed for each phase of the hormonal transition.
Progesterone tends to decline first, often years before estrogen. This creates an estrogen-dominant environment that drives irregular cycles, sleep disruption, anxiety, and early vasomotor symptoms.
Rapid estrogen decline drives vasomotor symptoms, genitourinary changes, bone loss acceleration, cardiovascular risk increase, and cognitive changes. The window for HRT benefit is widest within 10 years of menopause or before age 60.
Ongoing hormonal support maintains bone density, cardiovascular health, cognitive function, and quality of life. Protocol composition evolves as absolute hormone levels stabilize.
Required for accurate calculation of free testosterone and free estradiol. Without albumin, bioavailable hormone calculations are unreliable.
Two decades of post-WHI research have clarified the picture: for appropriately selected patients within the timing window, bioidentical HRT preserves bone density, meaningfully improves quality of life, and may offer cardiometabolic benefit. The evidence is there. The access has not kept pace.
Transdermal estrogen: no increased clot or stroke risk vs. oral forms
Bioidentical progesterone: safer breast profile vs. synthetic progestins
Testosterone: the most underrecognized deficiency in women's health

Every Crimson women’s health protocol begins with a full hormonal workup and is designed by a physician, not an algorithm.
01
Total Testosterone, Free Testosterone, SHBG, Albumin, LH, FSH, Estradiol, Progesterone, Hemoglobin, Hematocrit, TSH, Vitamin D, hsCRP, Free T3, Free T4, and Ferritin: 16 markers that together give a complete picture of the female hormonal system.
02
A licensed physician reviews your complete panel, evaluates your symptoms and phase of life, and designs a protocol calibrated to your biology.
03
Regular biomarker retesting produces specific, actionable data. Your physician adjusts dose, formulation, or protocol additions based on what the numbers show.
04
Hormonal needs change across life stages. Crimson tracks your hormonal picture over time and adjusts your protocol from perimenopause through menopause and beyond.
Crimson uses bioidentical hormones in delivery formats selected based on your symptom profile, uterine status, and individual risk factors. Estrogen, progesterone, and testosterone all decline at menopause. A complete protocol addresses all three.

Women produce measurable testosterone and lose it at menopause.

Compounded topical testosterone applied to the inner arm or thigh.

A compounded transdermal cream combining estradiol and estriol.

Bioidentical micronized progesterone, structurally identical to endogenously produced progesterone.

Compounded transdermal progesterone for women who cannot tolerate oral progesterone or prefer a topical route.
Member-only pricing on all treatments
Female hair loss rarely has a single cause. Estrogen decline, thyroid changes, iron deficiency, and hormone sensitivity all play a role. Widespread shedding triggered by hormonal shifts is often written off as normal aging. Crimson assesses the full hormonal picture (estradiol, free testosterone, DHEA-S, thyroid, and ferritin) before selecting a protocol.


Compounded topical serum combining minoxidil, tretinoin, biotin, fluocinolone, and Vitamin E.

Oral compounded capsule combining minoxidil and spironolactone.

Topical copper peptide serum targeting follicular microenvironment health.
Member-only pricing on all treatments
Labs are live. Begin with a comprehensive hormonal and metabolic workup and be among the first to access Crimson Women’s Health protocols.
Become a Member